|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1096535339 |
| 003 |
OCoLC |
| 005 |
20240809213013.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
190413s2019 nju o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d REDDC
|d OCLCF
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|d SXB
|d OCLCQ
|
| 020 |
|
|
|a 9781119285519
|
| 020 |
|
|
|a 1119285518
|
| 035 |
|
|
|a (OCoLC)1096535339
|
| 050 |
|
4 |
|a RS192
|b .C446 2019
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Am Ende, David J.
|
| 245 |
1 |
0 |
|a Chemical Engineering in the Pharmaceutical Industry, R & d to Manufacturing
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2019.
|
| 300 |
|
|
|a 1 online resource (685 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro; TITLE PAGE; COPYRIGHT PAGE; CONTENTS; LIST OF CONTRIBUTORS; PREFACE; UNIT CONVERSIONS; PART I INTRODUCTION; CHAPTER 1 CHEMICAL ENGINEERING IN THE PHARMACEUTICAL INDUSTRY; 1.1 GLOBAL IMPACT OF THE INDUSTRY; 1.2 INVESTMENTS IN PHARMACEUTICAL R 1.3 BEST SELLERS; 1.4 PHARMACEUTICAL RESEARCH AND DEVELOPMENT EXPENDITURES; 1.5 RECENT TRENDS FOR PHARMACEUTICAL DRUG AND MANUFACTURING; 1.6 CHEMICAL ENGINEERS SKILLED TO IMPACT FUTURE OF PHARMACEUTICAL INDUSTRY; REFERENCES; PART II DRUG PRODUCT DESIGN, DEVELOPMENT, AND MODELING; CHAPTER 2 DESIGN OF SOLID DOSAGE FORMULATIONS; 2.1 INTRODUCTION
|
| 505 |
8 |
|
|a 2.2 UNDERSTANDING DRUG SUBSTANCE2.3 EXCIPIENTS; 2.4 DRUG-EXCIPIENT COMPATIBILITY STUDY; 2.5 PROCESSING OF FORMULATIONS; 2.6 TABLET FORMULATION DESIGN; 2.7 TABLET CHARACTERISTICS; 2.8 USING DISSOLUTION TO DETERMINE CQAs; 2.9 DRUG PRODUCT STABILITY; 2.10 PROCESS OPERATIONS AND SCALABILITY OF DOSAGE FORM; 2.11 CONCLUDING REMARKS; REFERENCES; CHAPTER 3 POWDER PROCESS CHALLENGES AND SOLUTIONS; 3.1 INTRODUCTION; 3.2 COMMON POWDER-HANDLING EQUIPMENT; 3.3 POWDER FLOW AND SEGREGATION CONCERNS; 3.4 MEASUREMENT OF FLOW PROPERTIES
|
| 505 |
8 |
|
|a 3.5 TROUBLE-SHOOTING POWDER-HANDLING PROBLEMS AND EQUIPMENT DESIGN METHODSREFERENCES; CHAPTER 4 DESIGN AND SCALE-UP OF DRY GRANULATION PROCESSES; 4.1 OVERVIEW OF THE DRY GRANULATION PROCESS; 4.2 GENERAL CONSIDERATIONS FOR ROLLER COMPACTION OPERATIONS AND EQUIPMENT; 4.3 MATERIAL BEHAVIOR, QUALITY ATTRIBUTES, AND TESTING; 4.4 PRINCIPLES OF OPERATION; 4.5 SCALE-UP OF ROLLER COMPACTION; 4.6 SUMMARY; REFERENCES; CHAPTER 5 MODEL-BASED DEVELOPMENT OF ROLLER COMPACTION PROCESSES; 5.1 INTRODUCTION; 5.2 ROLL COMPACTION; 5.3 MILLING
|
| 505 |
8 |
|
|a 5.4 PROPERTY FUNCTIONS FOR MODEL-BASED DEVELOPMENT OF ROLLER COMPACTION5.5 CONNECTING PROCESS AND PROPERTY MODELS; 5.6 SUMMARY; 5.7 NOTATION; REFERENCES; CHAPTER 6 WET GRANULATION PROCESSES; 6.1 INTRODUCTION; 6.2 MECHANISMS IN WET GRANULATION; 6.3 SCALE-UP; 6.4 FUTURE DIRECTIONS; REFERENCES; CHAPTER 7 TOWARD A GENERIC MODEL FOR TWIN-SCREW WET GRANULATION; 7.1 INTRODUCTION; 7.2 EXPERIMENTAL DATA COLLECTION; 7.3 GRANULE SIZE DISTRIBUTIONS AT DIFFERENT LOCATIONS; 7.4 PBM MODEL DEVELOPMENT; 7.5 PBM MODEL CALIBRATION; 7.6 RESULTS FOR THE WETTING ZONE 1; 7.7 RESULTS FOR THE FIRST KNEADING ZONE 3
|
| 505 |
8 |
|
|a 7.8 RESULTS FOR THE SECOND KNEADING ZONE 67.9 RESULTS OF DIRECT SIMULATION FROM PREBLEND TO FINAL GRANULES AT TSG OUTLET (ZONES 1-6); 7.10 OUTLOOK; REFERENCES; CHAPTER 8 MODELING A DOSATOR CAPSULE FILLING PROCESS FOR HARD-SHELL CAPSULES; 8.1 OVERVIEW OF THE DOSATOR CAPSULE FILLING PROCESS; 8.2 DEM MODEL OF THE DOSATOR PROCESS; 8.3 MODELING RESULTS FOR THE DOSATOR FILLING PROCESS; 8.4 CASE STUDY: PREDICTION OF OPTIMAL INSERTION DEPTH INTO THE POWDER BED DURING A DOSATOR FILLING PROCESS; 8.5 SUMMARY; REFERENCES; CHAPTER 9 POWDER COMPACTION; 9.1 INTRODUCTION
|
| 500 |
|
|
|a 9.2 MECHANICS OF TABLET COMPRESSION: SIMPLE BEGINNINGS
|
| 650 |
|
0 |
|a Biochemical engineering.
|
| 650 |
|
0 |
|a Chemical engineering.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
7 |
|a chemical engineering.
|2 aat
|
| 650 |
|
7 |
|a Biochemical engineering
|2 fast
|
| 650 |
|
7 |
|a Chemical engineering
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical technology
|2 fast
|
| 700 |
1 |
|
|a Am Ende, Mary Tanya.
|
| 776 |
0 |
8 |
|i Print version:
|a Am Ende, David J.
|t Chemical Engineering in the Pharmaceutical Industry, R & d to Manufacturing.
|d Newark : John Wiley & Sons, Incorporated, ©2019
|z 9781119285496
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=5744611
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|